Serological landscape of cytokines in cutaneous melanoma

A vaccine targeting basic fibroblast growth factor elicits a protective immune response against murine melanoma

(2018) Xiaoping Zhang et al.   CANCER BIOLOGY & THERAPY

Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo

(2018) Nigel G. Kooreman et al.   Cell Stem Cell

Evaluation of the eighth American Joint Committee on Cancer staging system for malignant melanoma of the skin

(2018) Omar Abdel-Rahman   Future Oncology

The Metastatic Microenvironment: Melanoma-Microglia Cross-Talk Promotes the Malignant Phenotype of Melanoma Cells

(2018) Sivan Izraely et al.   INTERNATIONAL JOURNAL OF CANCER

Combination immunotherapies implementing adoptive T-cell transfer for advanced-stage melanoma

(2018) Kendra C. Foley et al.   MELANOMA RESEARCH

CCL20 Expression by Tumor-Associated Macrophages Predicts Progression of Human Primary Cutaneous Melanoma

(2018) Rafael Samaniego et al.   Cancer Immunology Research

Eighth American Joint Committee on Cancer (AJCC) melanoma classification: what about stage IIC?

(2018) G. Brancaccio et al.   BRITISH JOURNAL OF DERMATOLOGY

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy?

(2017) Federica Zito Marino et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3

(2017) Teilo H. Schaller et al.   Expert Review of Clinical Immunology

An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition

(2017) Helen L. Young et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Risk Factors for Melanoma in Renal Transplant Recipients

(2017) Mona Ascha et al.   JAMA Dermatology

Inflammatory Cytokine Pattern Is Sex-Dependent in Mouse Cutaneous Melanoma Experimental Model

(2017) Mihaela Surcel et al.   Journal of Immunology Research

Activated Natural Killer Cells Mediate the Suppressive Effect of Interleukin-4 on Tumor Development via STAT6 Activation in an Atopic Condition Melanoma Model

(2017) Dong Ju Son et al.   NEOPLASIA

Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma

(2017) Rahima Jamal et al.   Journal for ImmunoTherapy of Cancer

An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel

(2016) S. Thurneysen et al.   BRITISH JOURNAL OF DERMATOLOGY

State of the science on prevention and screening to reduce melanoma incidence and mortality: The time is now

(2016) Mary K. Tripp et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases

(2016) Ileana S. Mauldin et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Metastatic melanoma and immunotherapy

(2016) Benjamin Herzberg et al.   CLINICAL IMMUNOLOGY

Aqueous immune mediators in malignant uveal melanomas in comparison to benign pigmented intraocular tumors

(2016) Yoshihiko Usui et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab

(2015) Y. Koguchi et al.   CANCER RESEARCH

Role of IL-10 and TGF-βin melanoma

(2015) Arlina P. Wiguna et al.   EXPERIMENTAL DERMATOLOGY

C-Reactive Protein As a Marker of Melanoma Progression

(2015) Shenying Fang et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemokines in the Melanoma Metastasis Biomarkers Portrait

(2015) Monica Neagu et al.   JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY

Astrocytes facilitate melanoma brain metastasis via secretion of IL-23

(2015) Anat Klein et al.   JOURNAL OF PATHOLOGY

25-OH Vitamin D and Interleukin-8: Emerging Biomarkers in Cutaneous Melanoma Development and Progression

(2015) Corina-Daniela Ene et al.   MEDIATORS OF INFLAMMATION

Skin Cancer Epidemiology, Detection, and Management

(2015) Sumul Ashok Gandhi et al.   MEDICAL CLINICS OF NORTH AMERICA

Biomarkers for personalized oncology: recent advances and future challenges

(2015) Madhu Kalia   METABOLISM-CLINICAL AND EXPERIMENTAL

Decreased Interferon γ Production in CD3+ and CD3−CD56+ Lymphocyte Subsets in Metastatic Regional Lymph Nodes of Melanoma Patients

(2015) Ana Vuletić et al.   PATHOLOGY & ONCOLOGY RESEARCH

Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy

(2015) Helena Cirenajwis et al.   Oncotarget

Melanoma immunotherapy

(2014) Martina Sanlorenzo et al.   CANCER BIOLOGY & THERAPY

Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment

(2014) Chiara Camisaschi et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Identification of melanoma biomarkers based on network modules by integrating the human signaling network with microarrays

(2014) Lianjun Chen et al.   Journal of Cancer Research and Therapeutics

Molecular markers in melanoma

(2013) M. Kashani-Sabet   BRITISH JOURNAL OF DERMATOLOGY

Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review

(2013) Z.V. Fong et al.   BRITISH JOURNAL OF DERMATOLOGY

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

(2013) Deborah A. Knight et al.   JOURNAL OF CLINICAL INVESTIGATION

Immune Parameters in The Prognosis and Therapy Monitoring of Cutaneous Melanoma Patients: Experience, Role, and Limitations

(2013) Monica Neagu et al.   Biomed Research International

Interferon-γ-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells

(2012) Martina J Schmitt et al.   Cell Communication and Signaling

Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma

(2012) K. Harbst et al.   CLINICAL CANCER RESEARCH

Host-Derived MCP-1 and MIP-1α Regulate Protective Anti-Tumor Immunity to Localized and Metastatic B16 Melanoma

(2011) Yuko Nakasone et al.   AMERICAN JOURNAL OF PATHOLOGY

Molecular analysis of melanoma-induced sentinel lymph node immune dysfunction

(2011) Jonathan H. Lee et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Association of IFN-  Signal Transduction Defects with Impaired HLA Class I Antigen Processing in Melanoma Cell Lines

(2011) A. Respa et al.   CLINICAL CANCER RESEARCH

MC1R genotypes and risk of melanoma before age 40 years: A population-based case-control-family study

(2011) Anne E. Cust et al.   INTERNATIONAL JOURNAL OF CANCER

IL8 and Cathepsin B as Melanoma Serum Biomarkers

(2011) Hongtao Zhang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer

(2011) Athanassios Argiris et al.   ORAL ONCOLOGY

Immune-related biomarkers for diagnosis/prognosis and therapy monitoring of cutaneous melanoma

(2010) Monica Neagu et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma

(2010) Anne E. Cust et al.   INTERNATIONAL JOURNAL OF CANCER

Interferons Induce CXCR3-cognate Chemokine Production by Human Metastatic Melanoma

(2010) Lynn T. Dengel et al.   JOURNAL OF IMMUNOTHERAPY

Biomarkers of metastatic melanoma

(2009) Monica Neagu et al.   Biomarkers in Medicine